Inogen (INGN) Cost of Revenue (2013 - 2026)

Inogen (INGN) has reported Cost of Revenue for 14 consecutive years, with $51.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cost of Revenue rose 1.72% year-over-year to $51.8 million in Q2 2026; TTM through Jun 2026 was $196.6 million, a 4.51% increase from a year earlier, with the FY2025 full-year figure at $194.4 million, up 7.43% from the prior year.
• Cost of Revenue was $51.8 million for Q2 2026 at Inogen, up from $47.2 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $62.6 million in Q3 2022 and troughed at $41.4 million in Q1 2023.
• A 5-year average of $49.3 million and a median of $47.6 million in 2023 frame the typical range for Cost of Revenue.
• Across the five-year window, Cost of Revenue soared 55.02% in 2022 and slipped 19.79% in 2023, its largest moves.
• Over 5 years, Cost of Revenue stood at $58.6 million in 2022, then slipped by 18.56% to $47.7 million in 2023, then declined by 8.27% to $43.8 million in 2024, then advanced by 6.15% to $46.5 million in 2025, then grew by 11.46% to $51.8 million in 2026.
• The last three Cost of Revenue figures came in at $51.8 million (Q2 2026), $47.2 million (Q1 2026), and $46.5 million (Q4 2025), per Business Quant data.